M. Melikoglu Et Al. , "Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.," 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals , vol.46, Louisiana, United States Of America, 2002
Melikoglu, M. Et Al. 2002. Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.. 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals , (Louisiana, United States Of America).
Melikoglu, M., Fresko, I., Mat, C., Ozyazgan, Y., Gogus, F., Yurdakul, S., ... Hamuryudan, V.(2002). Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial. . 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Louisiana, United States Of America
Melikoglu, M Et Al. "Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.," 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Louisiana, United States Of America, 2002
Melikoglu, M Et Al. "Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.." 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals , Louisiana, United States Of America, 2002
Melikoglu, M. Et Al. (2002) . "Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.." 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals , Louisiana, United States Of America.
@conferencepaper{conferencepaper, author={M Melikoglu Et Al. }, title={Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.}, congress name={66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals}, city={Louisiana}, country={United States Of America}, year={2002}}